Breaking the Ice: Rethinking Endometrial Ablation

On-Demand Webinar
HCP Resources Page
image
Description
With value-based and patient-centered initiatives taking center stage in the healthcare industry, tailoring HMB treatment to effectively address current and future patient needs is the crucial next step for gynecologists. In this expert-led webinar, three nationally recognized OBGYNs discuss how emerging innovations and clinically proven technologies are revolutionizing the treatment paradigm for heavy menstrual bleeding (HMB). This session provides expert perspectives and clinical insights into the major questions facing gynecologists treating patients with HMB. Key Takeaways
  1. Challenges in Treating HMB: The webinar discusses past and present hurdles when achieving positive short- and long-term clinical outcomes for patients with HMB, specifically concerning tolerability, safety, and effectiveness. Long-term challenges include intrauterine scarring, cyclic pelvic pain, and limited uterine cavity visualization for future diagnostic needs.
  2. Limitations in Current Ablation Techniques: The session dives into the different ablation techniques that are used, identifying the challenges and advantages of each, with a critical distinction between heat-based and cold-based methods. The speakers discuss how each method impacts clinical outcomes in addition to the patient experience.
  3. Innovations With Cryotherapy: The discussion concludes with an in-depth exploration of recent innovations in cryotherapy with the Cerene® Cryotherapy Device. Based on recent studies, Cerene provides a safe, effective, and well-tolerated cryoablation procedure that is clinically proven to reduce heavy bleeding, relieve menstrual cramping, and result in minimal adhesions.
Complete the Form Below to View
Now Playing
Video Library
Rhonda Schafer-McLean, MD and her patient, Brooke, discuss how and why the Cerene Cryotherapy Device was the right treatment option for Brooke’s heavy menstrual bleeding symptoms.
GYN experts, Taraneh Shirazian, MD, Richard Salter, MD and Barbara Levy, MD, explore how women’s health professionals can make heavy menstrual bleeding care more patient-centered with new innovations in cryotherapy.
Barbara Levy, MD moderates a discussion with Geoffrey Bowers, MD and Leslie Hansen Lindner, MD on their insights on the evolution of endometrial ablation and how innovations in cryotherapy may reshape thinking around heavy menstrual bleeding treatment.
A compilation of physician perspectives on the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
Barbara Levy, MD discusses the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
James Greenberg, MD and Barbara Levy, MD discuss the implications from recent and historical publications on the rates of hysterectomy after an endometrial ablation.
James Coad, MD and Andrew Brill, MD discuss the science and benefits of cryotherapy for endometrial ablation.
Barbara Levy, MD and Todd Rumsey, MD discuss patient selection criteria for the Cerene Cryotherapy Device (27 minutes).
Barbara Levy, MD along with panelists Robert Rubino, MD, Richard Salter, MD, and Shannon Smith, MD provide insights into the management of menorrhagia. (59 minutes)
Barbara Levy, MD and Gerard Reilly, MD discuss how new innovations in cryotherapy are transforming the treatment of heavy menstrual bleeding. (45 minutes)

Important Safety Information

Cerene® Cryotherapy Device is indicated to ablate the endometrial lining of the uterus in premenopausal women with heavy menstrual bleeding due to benign causes for whom childbearing is complete. Pregnancy following the Cerene procedure can be dangerous; therefore, contraception must be used until menopause. The Cerene procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Cerene Cryotherapy Device. Temporary side effects may include cramping, nausea, vomiting, vaginal discharge and spotting. For detailed benefit and risk information, consult the Cerene Instructions for use (IFU) or your healthcare professional. Learn More